MODERN APPROACHES TO THE DIAGNOSIS AND TREATMENT OF INSULIN RESISTANCE
Abstract
Insulin resistance is a central pathological mechanism in metabolic syndrome, type 2 diabetes mellitus, obesity, and nonalcoholic fatty liver disease. It is characterized by reduced sensitivity of peripheral tissues to insulin, leading to impaired glucose and lipid metabolism. Early detection and timely intervention are crucial to prevent metabolic and cardiovascular complications.
References
1. American Diabetes Association. Standards of Medical Care in Diabetes—2022. Diabetes Care. 2022;45(Suppl.1):S1–S264. https://doi.org/10.2337/dc22-SINT
2. Lee S.H., Park S.Y., Choi C.S. Insulin Resistance: From Mechanisms to Therapeutic Strategies. Diabetes & Metabolism Journal. 2022;46(1):15–37. https://doi.org/10.4093/dmj.2021.0280
3. James D.E., Stöckli J., Birnbaum M.J. The aetiology and molecular landscape of insulin resistance. Nature Reviews Molecular Cell Biology. 2021;22:751–771. https://doi.org/10.1038/s41580-021-00390-6
4. Petersen M.C., Shulman G.I. Mechanisms of insulin action and insulin resistance. Physiological Reviews. 2018/updated reviews cited in 2019–2021 literature.
5. Muscogiuri G. et al. Nutritional guidelines for the management of insulin resistance. Critical Reviews in Food Science and Nutrition. 2022;62(25):6947–6960. https://doi.org/10.1080/10408398.2021.1908223
6. Gołacki J., Matuszek M., Matyjaszek-Matuszek B. Link between insulin resistance and obesity: from diagnosis to treatment. Diagnostics. 2022;12(7):1681. https://doi.org/10.3390/diagnostics12071681
7. Reaven G.M. Role of insulin resistance in human disease. (Classic concept, still cited in 2019–2022 reviews).
